Clinical Trials Logo

Stage IVA Osteosarcoma AJCC v7 clinical trials

View clinical trials related to Stage IVA Osteosarcoma AJCC v7.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02470091 Completed - Clinical trials for Recurrent Osteosarcoma

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Start date: November 21, 2015
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well denosumab works in treating patients with osteosarcoma that has come back (recurrent) or does not respond to treatment (refractory). Immunotherapy with monoclonal antibodies, such as denosumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.